Viewing Study NCT05619666


Ignite Creation Date: 2025-12-24 @ 4:04 PM
Ignite Modification Date: 2026-01-02 @ 1:44 AM
Study NCT ID: NCT05619666
Status: UNKNOWN
Last Update Posted: 2022-11-17
First Post: 2022-11-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Acute Rehabilitation in Patients With COVID-19 Pneumonia
Sponsor: Institut za Rehabilitaciju Sokobanjska Beograd
Organization:

Study Overview

Official Title: Acute Rehabilitation in Patients With COVID-19 Pneumonia a Single Center Experience From a Developing Country
Status: UNKNOWN
Status Verified Date: 2022-11
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: COVID-19 can have different clinical manifestations including myalgia, arthralgia, neurological, cardiac, psychological and other manifestations.These patients are at greater risk of developing consequences of prolonged bed rest. Therefore physical medicine and rehabilitation could have an important role in the multidisciplinary treatment of these issues. Early respiratory and neuromuscular rehabilitation is necessary to improve functional physical limitations, performance, muscle strength, endurance as well as cognitive and emotional domains. Some studies proposed that rehabilitation protocols in the inpatient setting include early mobilisation, strength and endurance training with the aim of reducing weakness and dependency. This Study aimed to detect the effects of rehabilitation in patients with Covid-19 who were admitted in temporary Covid hospital in Serbia. Furthermore, to emphasize the importance of functional assessment of the patients, in identifying their problems and selections of priorities in planning the best therapeutic protocol.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: